GlaxoSmithKline plc (NYSE:GSK) Busy in Alliance with Meritor, Inc. (NYSE:MTOR), Diamondback Energy, Inc. (NASDAQ:FANG),

Ligand Pharma declared on Wednesday that its partner GlaxoSmithKline plc (NYSE:GSK) Trend Analysis has submission to the European Medicines Agency of a variation to the Marketing Authorization for Revolade (eltrombopag), looking an additional indication for the treatment of adult patients with severe aplastic anemia who have had an insufficient response to immunosuppressive therapy. Shares of GlaxoSmithKline plc (NYSE:GSK) traded at $45.62 by plunging -0.74% with price volatility of 0.85% for a week and 1.09% for a month. Its beta stands at 0.65 times.Autoparts maker Meritor, Inc. (NYSE:MTOR) Trend Analysis released on Wednesday that its Q4 net income attributable to the firm was $3M or $0.03 a share, as compared to $41M or $0.42 a share in the similar quarter previous year. Meritor, Inc. (NYSE:MTOR) stock has highest price of $13.96 in last session, beginning with a price of $12.91 and reported a gain of 12.87% to the closed at $13.86 with a day range of $12.67-$13.96. The stock is going forward its 52-week low with 127.59% and moving down from its 52 week high price with -8.45%.Diamondback Energy, Inc. (NASDAQ:FANG) Trend Analysis released that the pricing of secondary common stock offering of 2M shares 1,058,000 shares will be sold by sure entities controlled by Wexford Capital LP as well as 942,000 shares will be sold by Gulfport Energy Corporation. Diamondback Energy, Inc. (NASDAQ:FANG) stock hit highest price at $65.94, beginning with a price of $64.52 and reported a decrease of -3.99% to the closed at $64.81 with a day range of $64.25-$65.94. The total market capitalization remained 3.678 Billion, total volume of 3.24 Million shares held in the session was surprisingly higher than its average volume of 1328.73 shares.